Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Heart Failure
Interventions: DRUG: Metoprolol|DRUG: Placebo|DRUG: Candesartan|DRUG: Placebo
Sponsor: University Hospital, Akershus
Collaborators: University of Oslo|Norwegian Cancer Society|AstraZeneca